Today: 29 April 2026
Texas Instruments stock jumps 3.5% as chip shares rebound; what to watch next for TXN
2 February 2026
1 min read

Texas Instruments stock jumps 3.5% as chip shares rebound; what to watch next for TXN

New York, February 2, 2026, 14:02 (EST) — Regular session underway.

  • Shares of Texas Instruments climbed roughly 3.5% in afternoon trading, following a wider rally across the chip sector.
  • U.S. factory activity unexpectedly bounced back, boosting shares tied to industry.
  • Investors are now turning their attention to Texas Instruments’ investor webcast scheduled for Feb. 24.

Shares of Texas Instruments Inc rose 3.5% to $223.19 on Monday, bouncing back alongside the broader semiconductor sector as U.S. stocks recovered from early losses.

This matters since Texas Instruments is often seen as a key indicator for “analog” chips — the less flashy components that handle power management and signal conversion across factory equipment and vehicles. When TXN shifts on a big market day, investors usually interpret it as a clue about whether industrial demand is easing up or merely rebounding.

The rally comes amid a split tape: AI-driven spending remains robust in select areas, yet uncertainty from rates and tariffs rattles the cycle. Texas Instruments, with its heavy industrial and automotive focus, feels the economy’s rhythm right away through shifting order flows.

Chip stocks saw widespread gains as the iShares Semiconductor ETF climbed 2.7% and the VanEck Semiconductor ETF increased 2.0%. Analog Devices ticked up roughly 2.0%, Microchip Technology jumped 3.5%, and ON Semiconductor outpaced them all, rising 3.7%.

The Institute for Supply Management delivered a crucial boost, reporting that U.S. manufacturing activity grew in January following several months of decline. Its PMI, a diffusion index where readings over 50 indicate expansion, climbed to 52.6. Still, an economist at FHN Financial warned that ongoing tariff threats continue to “freeze” smaller companies, potentially dragging the index back down. Reuters

Investor sentiment brightened despite a drop in commodities, as attention shifted to a packed calendar of earnings and economic reports. “We’re heading into a new week with plenty of catalysts in front of us,” said Art Hogan of B. Riley Wealth, while key U.S. indexes nudged upward. Reuters

TXN dipped to $212.03 earlier but climbed back, hitting an intraday peak of $223.29. Trading volume hovered near 4.4 million shares.

Texas Instruments grabbed attention back in late January by forecasting March-quarter revenue that topped Wall Street’s expectations. The chipmaker highlighted strong growth driven by data centers, even while other sectors remained patchy.

Still, the “but” is hard to ignore. Analysts warn that Texas Instruments’ heavy investment in property and equipment sets a higher hurdle for returns. Plus, tariff-related uncertainty might dampen global demand—a concern that weighs more on a firm tied to industrial clients than one focused on a single AI product cycle. Reuters

Attention turns to Texas Instruments’ upcoming statements rather than its prior guidance. The company’s investor site shows a webcast set for Feb. 24, featuring investor relations chief Mike Beckman.

Stock Market Today

  • Mesoblast Shares Falter Amid Growing Uncertainty Over Growth Prospects
    April 28, 2026, 10:58 PM EDT. Mesoblast (ASX:MSB) shares closed at A$2.15, down 6.5% over the past week despite a 0.5% gain in the last day. The biopharma firm shows mixed signals: positive 1- and 3-year shareholder returns contrast with weaker short-term performance. Analysts highlight Mesoblast as 43.9% undervalued with a fair value target of A$3.83, driven by heart failure drug rexlemestrocel L, pending potential U.S. accelerated FDA approval. However, risks loom from slow Ryoncil sales and trial delays. Valuation models conflict; discounted cash flow suggests undervaluation at A$3.05, but a high price-to-sales ratio of 30.5x versus industry norms raises questions if the market overpays for growth or if assumptions are overstretched. Investors remain cautious amid uncertain future earnings and regulatory hurdles.

Latest article

AST SpaceMobile Stock’s May 11 Moment: FCC Win Meets BlueBird 7 Reality

AST SpaceMobile Stock’s May 11 Moment: FCC Win Meets BlueBird 7 Reality

29 April 2026
AST SpaceMobile will hold its first-quarter update call on May 11 after winning FCC approval to deploy a 248-satellite constellation for direct-to-device service. Shares fell 6.8% Tuesday, following the loss of its BlueBird 7 satellite in a failed launch. The company expects insurance to cover the loss and is targeting 45 satellites in orbit by end-2026. Investors are watching launch progress and commercial service timing.
OpenAI Target Miss Report Sends Oracle, CoreWeave and AI Stocks Lower

OpenAI Target Miss Report Sends Oracle, CoreWeave and AI Stocks Lower

29 April 2026
Oracle shares fell 4% and CoreWeave dropped 5.9% Tuesday after a Wall Street Journal report said OpenAI missed recent revenue and user targets. Nvidia, AMD, and Arm Holdings also declined, with the iShares Semiconductor ETF down 3.7%. OpenAI denied internal divisions and said its AI coding product Codex reached 4 million users. Oracle’s credit default swaps hit a two-week high amid concern over its $300 billion cloud deal with OpenAI.
Cisco stock pops to a fresh 52-week high — here’s what Wall Street is watching next
Previous Story

Cisco stock pops to a fresh 52-week high — here’s what Wall Street is watching next

Nebius (NBIS) stock rebounds after a wild session as Feb. 12 results loom
Next Story

Nebius (NBIS) stock rebounds after a wild session as Feb. 12 results loom

Go toTop